共 10 条
[1]
Campion GV,Lebsack ME,Lookabaugh J,et al.Doserange and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis and Rheumatism . 1996
[2]
Danis VA,March LM,Nelson DS,et al.Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. The Journal of Rheumatology . 1987
[3]
Elliott MJ,Elliott,ravinderN,et al.Treatmeat of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor-α. Arthritis and Rheumatism . 1993
[4]
Drevlow BE.Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis and Rheumatism . 1996
[5]
Dinarello CA.Interleukin-1 and Interleukin-1 antagonism. Blood . 1991
[6]
Duff GW.Cytokines and acute phase proteins in rheumatoid arthritis. Scandinavian Journal of Rheumatology . 1994
[7]
Molving J.Endotoxin-stimulated human monocyte secretion of interleukin-1, tumor necrosis factor alpha, and postaglandin E2 shows stable interindividual differences. Scandinavian Journal of Immunology . 1988
[8]
Maury CP,Andersson LC,Teppo A-M,et al.Mechanism of anaemia in rheumatoid arthritis: demonstration of raised inerleukin-1 beta concentrations in anemic patients and of interleukin-1 mediated suppression of normal erythropoieses and proliferation of human erythroleukaemia (HEL) cells in vitro. Annals of the Rheumatic Diseases . 1988
[9]
Wood NC,Symus JA,Duff GW,et al.Serum interleukin-2 receptor in rheumatoid arthritis: a prognostic indicator of disease activity. Journal of Autoimmunity . 1988
[10]
Seckinger P,Isaaz S,Dayer JM,et al.A human inhibitor of tumor necrosis factor. The Journal of Experimental Medicine . 1988